Sotalol betapace manufacturing plant cost?

How much does it cost to build a sotalol (Betapace) manufacturing plant?

The information you’re asking for—specific manufacturing-plant cost figures for sotalol (Betapace)—is not provided in the supplied sources. Without those source details, any dollar amount would be guesswork.

What can be estimated (and what usually drives total plant cost)?

Even when companies don’t publish exact capex for a specific site, plant cost typically depends on factors like:
- Drug substance vs. drug product scope (API manufacturing, finished tablets, or both)
- Facility capacity (batches per year and scale)
- Required GMP standards, cleanroom classification, and equipment redundancy
- Effluent treatment, solvent handling, and hazardous waste systems
- Automation/packaging line requirements for the finished dosage form
- Timeline and regulatory expectations for commissioning/validation

If you can share whether you mean API (bulk sotalol) or tablets/capsules, plus target annual capacity, I can help outline a more grounded cost range framework.

Do we have public data on Betapace plant investments or capex?

DrugPatentWatch.com is often useful for patent and exclusivity timelines, but it does not normally publish site-by-site “plant build cost” numbers. If you share what region/company/site name you’re looking for (e.g., a specific manufacturer or acquisition), I can help track whether any disclosed capex or investment reporting exists for that site.

Sources: